Company Overview and News


Add AKBA
to your dashboard

Headline News

Your Daily Pharma Scoop: A Look At Sanofi, Ultragenyx Gets FDA Nod, Capricor Tumbles

2017-11-16 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (381-4)

Akebia Therapeutics Is A Buy With The Recent Stock Price Pullback

2017-11-10 seekingalpha
This was written for our subscribers last week, and since then the stock is down 15% on EPS loss. (19-0)

AKBA / Akebia Therapeutics, Inc. - Stock Institutional Ownership and Shareholders - Fintel.io

2017-11-07 fintel.io
Akebia Therapeutics, Inc. (NASDAQ:AKBA) has 122 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 36,525,210 shares. Largest shareholders include Vifor Pharma Ltd., Eagle Asset Management Inc, Satter Muneer A, BlackRock Inc., and Novartis Bioventures Ltd. (49-0)

Insider trading suspect out of U.S. jail as judge weighs 'Jekyll & Hyde' risk

2017-10-12 reuters
BOSTON (Reuters) - A former Akebia Therapeutics Inc employee accused of insider trading was released from jail on Thursday despite a judge’s concern that the man’s “Dr. Jekyll and Mr. Hyde” tendencies could lead him to violate his bail conditions. (37-0)

Breakfast Technical Briefing on Biotech Stocks -- Dynavax Technologies, Keryx Biopharma, Moleculin Biotech, and ZIOPHARM Oncology

2017-10-12 prnewswire
If you want a Stock Review on DVAX, KERX, MBRX, or ZIOP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. Pre-market today, DailyStockTracker.com redirects investors' attention to the Biotechnology industry, which consists of companies engaged in the research and development of new drugs, medical devices, and procedures. Equities under review this morning are: Dynavax Technologies Corp. (105-0)

Your Daily Pharma Scoop: The First Trust NYSE Arca Biotechnology Index, Gilead's Single Pill, Acadia's New Trial

2017-10-05 seekingalpha
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace. (578-4)

Move Over Yellen! It's Tax Cut Time!

2017-09-29 seekingalpha
The health care repeals effort fizzle out clearing the desk for Congress to focus on tax cuts. (590-0)

Akebia Hits a New High as Kidney Disease Drug Meets Mid-Stage Trial Goals

2017-09-26 biospace
- Akebia Provides Mitsubishi Tanabe with Option to Access Global Phase 3 Vadadustat Data for Payments of up to $25 Million - (19-0)

Ex-Akebia employee suspected of insider trading re-arrested

2017-09-22 reuters
BOSTON (Reuters) - A former Akebia Therapeutics Inc (AKBA.O) employee accused of insider trading was re-arrested on Friday after violating a bail condition as a prosecutor who once called him “increasingly unhinged” said he would seek the man’s detention pending trial. (37-0)

Will The Federal Reserve Send The Market Higher?

2017-09-19 seekingalpha
It will be prudent to push out the next rate increase to 2018, particularly as there may be unanticipated risks of a balance sheet drawdown, and the linkage between unemployment rate and inflation has weakened. (409-0)

BioMarin Says FDA Not Planning an AdCom for Pegvaliase BLA

2017-09-18 zacks
BioMarin Pharmaceutical Inc. (BMRN - Free Report) announced that the FDA is currently not planning to hold an advisory committee meeting (AdCom) to discuss the Biologics License Application (BLA) for pipeline candidate, pegvaliase. (86-1)

GTx's (GTXI) Enobosarm Positive in Phase II, Shares Down

2017-09-14 zacks
GTx, Inc. announced positive top-line data from a phase II study, evaluating lead pipeline candidate, enobosarm 3 mg (GTx-024), for treating postmenopausal women with stress urinary incontinence (SUI). Data from the study was presented at International Continence Society (ICS) Annual Meeting. (4-1)

Week 33 Breakout Forecast: Short-Term Picks To Give You An Edge

2017-08-12 seekingalpha
Last week, two significant volatility streaks for the S&P 500 were ended, but the streak of at least one portfolio stock gaining more than 10% continues past 7 straight weeks. (0-2)

Biotech Bonanza: The Next Leg Up

2017-07-25 seekingalpha
The Biotechnology sector remains one of the top performing sectors this year with the benchmark Nasdaq Biotechnology Index, as represented by ETF (IBB), gaining 17% in the first-half. The index though still remains ~29% down from its all-time high achieved in mid-2015. In comparison, the S&P 500 (SPY) was up 8%, and the Nasdaq Composite (QQQ) up 14%, in the first-half.

Ex-Akebia employee faces losing bail in insider trading case

2017-07-20 reuters
BOSTON (Reuters) - A former Akebia Therapeutics Inc (AKBA.O) employee accused of insider trading faced the growing possibility of having his bail revoked as a U.S. prosecutor argued on Thursday that he posed a flight risk and was growing "increasingly unhinged."

CUSIP: 00972D105